Literature DB >> 4813369

Characterization of two mannose-containing oligosaccharides isolated from the urine of patients with mannosidosis.

N E Nordén, A Lundblad, S Svensson, S Autio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4813369     DOI: 10.1021/bi00702a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  6 in total

1.  Mannosidosis: tissue culture studies in relation to prenatal diagnosis.

Authors:  I Maire; M T Zabot; M Mathieu; J Cotte; M Hermier
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

2.  Isolation and characterization of oligosaccharides from urine of patients with abnormal glycoconjugate metabolism.

Authors:  M A Chester; A Lundblad; S Svensson; P A Ockerman
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

3.  Effects of the alpha-mannosidase inhibitors, 1,4-dideoxy-1,4-imino-D-mannitol and swainsonine, on glycoprotein catabolism in cultured macrophages.

Authors:  P F Daniel; D S Newburg; N E O'Neil; P W Smith; G W Fleet
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

4.  The catabolism of mammalian glycoproteins. Comparison of the storage products in bovine, feline and human mannosidosis.

Authors:  D Abraham; W F Blakemore; R D Jolly; R Sidebotham; B Winchester
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

5.  The substrate-specificity of human lysosomal alpha-D-mannosidase in relation to genetic alpha-mannosidosis.

Authors:  S al Daher; R de Gasperi; P Daniel; N Hall; C D Warren; B Winchester
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

6.  Transfer of free polymannose-type oligosaccharides from the cytosol to lysosomes in cultured human hepatocellular carcinoma HepG2 cells.

Authors:  A Saint-Pol; C Bauvy; P Codogno; S E Moore
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.